Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death via inhibiting mTOR

MLA

Boah Lee, et al. “Lomitapide, a Cholesterol-Lowering Drug, Is an Anticancer Agent That Induces Autophagic Cell Death via Inhibiting MTOR.” Cell Death and Disease, vol. 13, no. 7, July 2022, pp. 1–14. EBSCOhost, https://doi.org/10.1038/s41419-022-05039-6.

APA

Boah Lee, Seung Ju Park, Seulgi Lee, Jinwook Lee, Eunbeol Lee, Eun-Seon Yoo, Won-Suk Chung, Jong-Woo Sohn, Byung-Chul Oh, & Seyun Kim. (2022). Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death via inhibiting mTOR. Cell Death and Disease, 13(7), 1–14. https://doi.org/10.1038/s41419-022-05039-6

Chicago

Boah Lee, Seung Ju Park, Seulgi Lee, Jinwook Lee, Eunbeol Lee, Eun-Seon Yoo, Won-Suk Chung, Jong-Woo Sohn, Byung-Chul Oh, and Seyun Kim. 2022. “Lomitapide, a Cholesterol-Lowering Drug, Is an Anticancer Agent That Induces Autophagic Cell Death via Inhibiting MTOR.” Cell Death and Disease 13 (7): 1–14. doi:10.1038/s41419-022-05039-6.